Listed in the December 27, 2023 extract; not in the current extract (September 22, 2026): Clindamycin Phosphate Topical Solution (02483769). Source: odb-formulary-ed43-extract-2023-12-27.xml; compared with odb-formulary-ed43-extract-2026-09-22.xml.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Clindamycin HCL
20 general benefit · 2 not a benefit
Auro-Clindamycin · DIN 02436906 · 150 mg · capsule
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
1 brand, same coverage
Auro-Clindamycin · DIN 02436906
Manufacturer: Auro Pharma Inc.; listing date 2015-05-28
Daily cost (source): $1.7736
Health Canada: Marketed since 2015-03-02 · brand AURO-CLINDAMYCIN · ATC J01FF01 CLINDAMYCIN · form Capsule · route Oral · ingredients CLINDAMYCIN (CLINDAMYCIN HYDROCHLORIDE) 150 MG · company Auro pharma inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordAuro-Clindamycin: Formulary list price $0.22 per unit (the source does not state the unit; exact figure $0.2217). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02436906)
Source record
DIN 02436906: Auro-Clindamycin
Raw flags: sec3=Y
Item: 081228006; group id 44; item number 0100; lccId None; manufacturer id AUR
Source form: Cap; strength: 150mg
Recorded listing: General benefit
Source prices (unrounded): $0.2217; ministry $0.2217
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02436906
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=92122
Interchangeable products
Apo-Clindamycin · DIN 02245232 · $0.2217
Clindamycin · DIN 02400529 · $0.2217
Dalacin C · DIN 00030570 · not recorded
Jamp Clindamycin Capsules · DIN 02557878 · $0.2217
Jamp-Clindamycin · DIN 02483734 · $0.2217
M-Clindamycin · DIN 02479923 · $0.2217
Med-Clindamycin · DIN 02462656 · $0.2217
NRA-Clindamycin · DIN 02493748 · $0.2217
Riva-Clindamycin · DIN 02468476 · $0.2217
Teva-Clindamycin · DIN 02241709 · $0.2217
Shortage status: resolved shortage (ended August 30, 2022); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02436906
Shortage record checked October 6, 2026
Clindamycin · DIN 02400529 · 150 mg · capsule
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
1 brand, same coverage
Clindamycin · DIN 02400529
Manufacturer: Sanis Health Inc.; listing date 2022-04-29
Daily cost (source): $1.7736
Health Canada: Marketed since 2022-02-11 · brand CLINDAMYCIN · ATC J01FF01 CLINDAMYCIN · form Capsule · route Oral · ingredients CLINDAMYCIN (CLINDAMYCIN HYDROCHLORIDE) 150 MG · company Sanis health inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordClindamycin: Formulary list price $0.22 per unit (the source does not state the unit; exact figure $0.2217). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02400529)
Source record
DIN 02400529: Clindamycin
Raw flags: sec3=Y
Item: 081228006; group id 44; item number 0100; lccId None; manufacturer id SAI
Source form: Cap; strength: 150mg
Recorded listing: General benefit
Source prices (unrounded): $0.2217; ministry $0.2217
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02400529
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=88532
Interchangeable products
Apo-Clindamycin · DIN 02245232 · $0.2217
Auro-Clindamycin · DIN 02436906 · $0.2217
Dalacin C · DIN 00030570 · not recorded
Jamp Clindamycin Capsules · DIN 02557878 · $0.2217
Jamp-Clindamycin · DIN 02483734 · $0.2217
M-Clindamycin · DIN 02479923 · $0.2217
Med-Clindamycin · DIN 02462656 · $0.2217
NRA-Clindamycin · DIN 02493748 · $0.2217
Riva-Clindamycin · DIN 02468476 · $0.2217
Teva-Clindamycin · DIN 02241709 · $0.2217
Shortage status: resolved shortage (ended March 23, 2018); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02400529
Shortage record checked October 6, 2026
Jamp Clindamycin Capsules · DIN 02557878 · 150 mg · capsule
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
1 brand, same coverage
Jamp Clindamycin Capsules · DIN 02557878
Manufacturer: Jamp Pharma Corporation; listing date 2026-09-29
Daily cost (source): $1.7736
Health Canada: Marketed since 2026-07-24 · brand JAMP CLINDAMYCIN CAPSULES · ATC J01FF01 CLINDAMYCIN · form Capsule · route Oral · ingredients CLINDAMYCIN (CLINDAMYCIN HYDROCHLORIDE) 150 MG · company Jamp pharma corporation · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordJamp Clindamycin Capsules: Formulary list price $0.22 per unit (the source does not state the unit; exact figure $0.2217). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02557878)
Source record
DIN 02557878: Jamp Clindamycin Capsules
Raw flags: sec3=Y
Item: 081228006; group id 44; item number 0100; lccId None; manufacturer id JPC
Source form: Cap; strength: 150mg
Recorded listing: General benefit
Source prices (unrounded): $0.2217; ministry $0.2217
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02557878
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=106116
Interchangeable products
Apo-Clindamycin · DIN 02245232 · $0.2217
Auro-Clindamycin · DIN 02436906 · $0.2217
Clindamycin · DIN 02400529 · $0.2217
Dalacin C · DIN 00030570 · not recorded
Jamp-Clindamycin · DIN 02483734 · $0.2217
M-Clindamycin · DIN 02479923 · $0.2217
Med-Clindamycin · DIN 02462656 · $0.2217
NRA-Clindamycin · DIN 02493748 · $0.2217
Riva-Clindamycin · DIN 02468476 · $0.2217
Teva-Clindamycin · DIN 02241709 · $0.2217
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02557878
Shortage record checked October 6, 2026
Jamp-Clindamycin · DIN 02483734 · 150 mg · capsule
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
1 brand, same coverage
Jamp-Clindamycin · DIN 02483734
Manufacturer: Jamp Pharma Corporation; listing date 2019-10-31
Daily cost (source): $1.7736
Health Canada: Marketed since 2019-09-27 · brand JAMP CLINDAMYCIN · ATC J01FF01 CLINDAMYCIN · form Capsule · route Oral · ingredients CLINDAMYCIN (CLINDAMYCIN HYDROCHLORIDE) 150 MG · company Jamp pharma corporation · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordJamp-Clindamycin: Formulary list price $0.22 per unit (the source does not state the unit; exact figure $0.2217). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02483734)
Source record
DIN 02483734: Jamp-Clindamycin
Raw flags: sec3=Y
Item: 081228006; group id 44; item number 0100; lccId None; manufacturer id JPC
Source form: Cap; strength: 150mg
Recorded listing: General benefit
Source prices (unrounded): $0.2217; ministry $0.2217
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02483734
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=97408
Interchangeable products
Apo-Clindamycin · DIN 02245232 · $0.2217
Auro-Clindamycin · DIN 02436906 · $0.2217
Clindamycin · DIN 02400529 · $0.2217
Dalacin C · DIN 00030570 · not recorded
Jamp Clindamycin Capsules · DIN 02557878 · $0.2217
M-Clindamycin · DIN 02479923 · $0.2217
Med-Clindamycin · DIN 02462656 · $0.2217
NRA-Clindamycin · DIN 02493748 · $0.2217
Riva-Clindamycin · DIN 02468476 · $0.2217
Teva-Clindamycin · DIN 02241709 · $0.2217
Shortage status: active shortage (reported September 15, 2026, estimated to end October 22, 2026, last updated September 23, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02483734
Shortage record checked October 6, 2026
M-Clindamycin · DIN 02479923 · 150 mg · capsule
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
1 brand, same coverage
M-Clindamycin · DIN 02479923
Manufacturer: Mantra Pharma Inc.; listing date 2021-09-30
Daily cost (source): $1.7736
Health Canada: Marketed since 2019-05-28 · brand M-CLINDAMYCIN · ATC J01FF01 CLINDAMYCIN · form Capsule · route Oral · ingredients CLINDAMYCIN (CLINDAMYCIN HYDROCHLORIDE) 150 MG · company Mantra pharma inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordM-Clindamycin: Formulary list price $0.22 per unit (the source does not state the unit; exact figure $0.2217). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02479923)
Source record
DIN 02479923: M-Clindamycin
Raw flags: sec3=Y
Item: 081228006; group id 44; item number 0100; lccId None; manufacturer id MAT
Source form: Cap; strength: 150mg
Recorded listing: General benefit
Source prices (unrounded): $0.2217; ministry $0.2217
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02479923
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=97049
Interchangeable products
Apo-Clindamycin · DIN 02245232 · $0.2217
Auro-Clindamycin · DIN 02436906 · $0.2217
Clindamycin · DIN 02400529 · $0.2217
Dalacin C · DIN 00030570 · not recorded
Jamp Clindamycin Capsules · DIN 02557878 · $0.2217
Jamp-Clindamycin · DIN 02483734 · $0.2217
Med-Clindamycin · DIN 02462656 · $0.2217
NRA-Clindamycin · DIN 02493748 · $0.2217
Riva-Clindamycin · DIN 02468476 · $0.2217
Teva-Clindamycin · DIN 02241709 · $0.2217
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02479923
Shortage record checked October 6, 2026
Med-Clindamycin · DIN 02462656 · 150 mg · capsule
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
1 brand, same coverage
Med-Clindamycin · DIN 02462656
Manufacturer: Generic Medical Partners Inc.; listing date 2022-04-29
Daily cost (source): $1.7736
Health Canada: Marketed since 2021-12-22 · brand MED-CLINDAMYCIN · ATC J01FF01 CLINDAMYCIN · form Capsule · route Oral · ingredients CLINDAMYCIN (CLINDAMYCIN HYDROCHLORIDE) 150 MG · company Generic medical partners inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordMed-Clindamycin: Formulary list price $0.22 per unit (the source does not state the unit; exact figure $0.2217). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02462656)
Source record
DIN 02462656: Med-Clindamycin
Raw flags: sec3=Y
Item: 081228006; group id 44; item number 0100; lccId None; manufacturer id GMP
Source form: Cap; strength: 150mg
Recorded listing: General benefit
Source prices (unrounded): $0.2217; ministry $0.2217
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02462656
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=95045
Interchangeable products
Apo-Clindamycin · DIN 02245232 · $0.2217
Auro-Clindamycin · DIN 02436906 · $0.2217
Clindamycin · DIN 02400529 · $0.2217
Dalacin C · DIN 00030570 · not recorded
Jamp Clindamycin Capsules · DIN 02557878 · $0.2217
Jamp-Clindamycin · DIN 02483734 · $0.2217
M-Clindamycin · DIN 02479923 · $0.2217
NRA-Clindamycin · DIN 02493748 · $0.2217
Riva-Clindamycin · DIN 02468476 · $0.2217
Teva-Clindamycin · DIN 02241709 · $0.2217
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02462656
Shortage record checked October 6, 2026
NRA-Clindamycin · DIN 02493748 · 150 mg · capsule
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
1 brand, same coverage
NRA-Clindamycin · DIN 02493748
Manufacturer: Nora Pharma; listing date 2020-10-30
Daily cost (source): $1.7736
Health Canada: Marketed since 2020-07-06 · brand NRA-CLINDAMYCIN · ATC J01FF01 CLINDAMYCIN · form Capsule · route Oral · ingredients CLINDAMYCIN (CLINDAMYCIN HYDROCHLORIDE) 150 MG · company Nora pharma inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordNRA-Clindamycin: Formulary list price $0.22 per unit (the source does not state the unit; exact figure $0.2217). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02493748)
Source record
DIN 02493748: NRA-Clindamycin
Raw flags: sec3=Y
Item: 081228006; group id 44; item number 0100; lccId None; manufacturer id NRA
Source form: Cap; strength: 150mg
Recorded listing: General benefit
Source prices (unrounded): $0.2217; ministry $0.2217
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02493748
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=98373
Interchangeable products
Apo-Clindamycin · DIN 02245232 · $0.2217
Auro-Clindamycin · DIN 02436906 · $0.2217
Clindamycin · DIN 02400529 · $0.2217
Dalacin C · DIN 00030570 · not recorded
Jamp Clindamycin Capsules · DIN 02557878 · $0.2217
Jamp-Clindamycin · DIN 02483734 · $0.2217
M-Clindamycin · DIN 02479923 · $0.2217
Med-Clindamycin · DIN 02462656 · $0.2217
Riva-Clindamycin · DIN 02468476 · $0.2217
Teva-Clindamycin · DIN 02241709 · $0.2217
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02493748
Shortage record checked October 6, 2026
Teva-Clindamycin · DIN 02241709 · 150 mg · capsule
General benefitMarketed · checked November 17, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
1 brand, same coverage
Teva-Clindamycin · DIN 02241709
Manufacturer: Teva Canada Limited; listing date 2000-11-30
Daily cost (source): $1.7736
Health Canada: Marketed since 2011-01-24 · brand TEVA-CLINDAMYCIN · ATC J01FF01 CLINDAMYCIN · form Capsule · route Oral · ingredients CLINDAMYCIN (CLINDAMYCIN HYDROCHLORIDE) 150 MG · company Teva canada limited · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordTeva-Clindamycin: Formulary list price $0.22 per unit (the source does not state the unit; exact figure $0.2217). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02241709)
Source record
DIN 02241709: Teva-Clindamycin
Raw flags: sec3=Y
Item: 081228006; group id 44; item number 0100; lccId None; manufacturer id TEV
Source form: Cap; strength: 150mg
Recorded listing: General benefit
Source prices (unrounded): $0.2217; ministry $0.2217
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02241709
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=65371
Interchangeable products
Apo-Clindamycin · DIN 02245232 · $0.2217
Auro-Clindamycin · DIN 02436906 · $0.2217
Clindamycin · DIN 02400529 · $0.2217
Dalacin C · DIN 00030570 · not recorded
Jamp Clindamycin Capsules · DIN 02557878 · $0.2217
Jamp-Clindamycin · DIN 02483734 · $0.2217
M-Clindamycin · DIN 02479923 · $0.2217
Med-Clindamycin · DIN 02462656 · $0.2217
NRA-Clindamycin · DIN 02493748 · $0.2217
Riva-Clindamycin · DIN 02468476 · $0.2217
Shortage status: active shortage (reported October 8, 2025, last updated October 10, 2025); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02241709
Shortage record checked October 6, 2026
Auro-Clindamycin · DIN 02436914 · 300 mg · capsule
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
1 brand, same coverage
Auro-Clindamycin · DIN 02436914
Manufacturer: Auro Pharma Inc.; listing date 2015-05-28
Health Canada: Marketed since 2015-03-02 · brand AURO-CLINDAMYCIN · ATC J01FF01 CLINDAMYCIN · form Capsule · route Oral · ingredients CLINDAMYCIN (CLINDAMYCIN HYDROCHLORIDE) 300 MG · company Auro pharma inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordAuro-Clindamycin: Formulary list price $0.44 per unit (the source does not state the unit; exact figure $0.4434). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02436914)
Source record
DIN 02436914: Auro-Clindamycin
Raw flags: sec3=Y
Item: 081228088; group id 44; item number 0101; lccId None; manufacturer id AUR
Source form: Cap; strength: 300mg
Recorded listing: General benefit
Source prices (unrounded): $0.4434; ministry $0.4434
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02436914
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=92123
Interchangeable products
Apo-Clindamycin · DIN 02245233 · $0.4434
Clindamycin · DIN 02400537 · $0.4434
Dalacin C · DIN 02182866 · not recorded
Jamp Clindamycin Capsules · DIN 02557886 · $0.4434
Jamp-Clindamycin · DIN 02483742 · $0.4434
M-Clindamycin · DIN 02479931 · $0.4434
Med-Clindamycin · DIN 02462664 · $0.4434
NRA-Clindamycin · DIN 02493756 · $0.4434
Riva-Clindamycin · DIN 02468484 · $0.4434
Teva-Clindamycin · DIN 02241710 · $0.4434
Shortage status: avoided shortage; reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02436914
Shortage record checked October 6, 2026
Clindamycin · DIN 02400537 · 300 mg · capsule
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
1 brand, same coverage
Clindamycin · DIN 02400537
Manufacturer: Sanis Health Inc.; listing date 2022-04-29
Health Canada: Marketed since 2022-02-11 · brand CLINDAMYCIN · ATC J01FF01 CLINDAMYCIN · form Capsule · route Oral · ingredients CLINDAMYCIN (CLINDAMYCIN HYDROCHLORIDE) 300 MG · company Sanis health inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordClindamycin: Formulary list price $0.44 per unit (the source does not state the unit; exact figure $0.4434). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02400537)
Source record
DIN 02400537: Clindamycin
Raw flags: sec3=Y
Item: 081228088; group id 44; item number 0101; lccId None; manufacturer id SAI
Source form: Cap; strength: 300mg
Recorded listing: General benefit
Source prices (unrounded): $0.4434; ministry $0.4434
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02400537
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=88533
Interchangeable products
Apo-Clindamycin · DIN 02245233 · $0.4434
Auro-Clindamycin · DIN 02436914 · $0.4434
Dalacin C · DIN 02182866 · not recorded
Jamp Clindamycin Capsules · DIN 02557886 · $0.4434
Jamp-Clindamycin · DIN 02483742 · $0.4434
M-Clindamycin · DIN 02479931 · $0.4434
Med-Clindamycin · DIN 02462664 · $0.4434
NRA-Clindamycin · DIN 02493756 · $0.4434
Riva-Clindamycin · DIN 02468484 · $0.4434
Teva-Clindamycin · DIN 02241710 · $0.4434
Shortage status: resolved shortage (ended March 23, 2018); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02400537
Shortage record checked October 6, 2026
Jamp Clindamycin Capsules · DIN 02557886 · 300 mg · capsule
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
1 brand, same coverage
Jamp Clindamycin Capsules · DIN 02557886
Manufacturer: Jamp Pharma Corporation; listing date 2026-09-29
Health Canada: Marketed since 2026-07-24 · brand JAMP CLINDAMYCIN CAPSULES · ATC J01FF01 CLINDAMYCIN · form Capsule · route Oral · ingredients CLINDAMYCIN (CLINDAMYCIN HYDROCHLORIDE) 300 MG · company Jamp pharma corporation · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordJamp Clindamycin Capsules: Formulary list price $0.44 per unit (the source does not state the unit; exact figure $0.4434). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02557886)
Source record
DIN 02557886: Jamp Clindamycin Capsules
Raw flags: sec3=Y
Item: 081228088; group id 44; item number 0101; lccId None; manufacturer id JPC
Source form: Cap; strength: 300mg
Recorded listing: General benefit
Source prices (unrounded): $0.4434; ministry $0.4434
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02557886
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=106117
Interchangeable products
Apo-Clindamycin · DIN 02245233 · $0.4434
Auro-Clindamycin · DIN 02436914 · $0.4434
Clindamycin · DIN 02400537 · $0.4434
Dalacin C · DIN 02182866 · not recorded
Jamp-Clindamycin · DIN 02483742 · $0.4434
M-Clindamycin · DIN 02479931 · $0.4434
Med-Clindamycin · DIN 02462664 · $0.4434
NRA-Clindamycin · DIN 02493756 · $0.4434
Riva-Clindamycin · DIN 02468484 · $0.4434
Teva-Clindamycin · DIN 02241710 · $0.4434
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02557886
Shortage record checked October 6, 2026
Jamp-Clindamycin · DIN 02483742 · 300 mg · capsule
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
1 brand, same coverage
Jamp-Clindamycin · DIN 02483742
Manufacturer: Jamp Pharma Corporation; listing date 2019-10-31
Health Canada: Marketed since 2019-09-27 · brand JAMP CLINDAMYCIN · ATC J01FF01 CLINDAMYCIN · form Capsule · route Oral · ingredients CLINDAMYCIN (CLINDAMYCIN HYDROCHLORIDE) 300 MG · company Jamp pharma corporation · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordJamp-Clindamycin: Formulary list price $0.44 per unit (the source does not state the unit; exact figure $0.4434). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02483742)
Source record
DIN 02483742: Jamp-Clindamycin
Raw flags: sec3=Y
Item: 081228088; group id 44; item number 0101; lccId None; manufacturer id JPC
Source form: Cap; strength: 300mg
Recorded listing: General benefit
Source prices (unrounded): $0.4434; ministry $0.4434
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02483742
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=97409
Interchangeable products
Apo-Clindamycin · DIN 02245233 · $0.4434
Auro-Clindamycin · DIN 02436914 · $0.4434
Clindamycin · DIN 02400537 · $0.4434
Dalacin C · DIN 02182866 · not recorded
Jamp Clindamycin Capsules · DIN 02557886 · $0.4434
M-Clindamycin · DIN 02479931 · $0.4434
Med-Clindamycin · DIN 02462664 · $0.4434
NRA-Clindamycin · DIN 02493756 · $0.4434
Riva-Clindamycin · DIN 02468484 · $0.4434
Teva-Clindamycin · DIN 02241710 · $0.4434
Shortage status: active shortage (reported September 15, 2026, estimated to end October 22, 2026, last updated September 23, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02483742
Shortage record checked October 6, 2026
M-Clindamycin · DIN 02479931 · 300 mg · capsule
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
1 brand, same coverage
M-Clindamycin · DIN 02479931
Manufacturer: Mantra Pharma Inc.; listing date 2021-09-30
Health Canada: Marketed since 2019-05-28 · brand M-CLINDAMYCIN · ATC J01FF01 CLINDAMYCIN · form Capsule · route Oral · ingredients CLINDAMYCIN (CLINDAMYCIN HYDROCHLORIDE) 300 MG · company Mantra pharma inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordM-Clindamycin: Formulary list price $0.44 per unit (the source does not state the unit; exact figure $0.4434). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02479931)
Source record
DIN 02479931: M-Clindamycin
Raw flags: sec3=Y
Item: 081228088; group id 44; item number 0101; lccId None; manufacturer id MAT
Source form: Cap; strength: 300mg
Recorded listing: General benefit
Source prices (unrounded): $0.4434; ministry $0.4434
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02479931
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=97050
Interchangeable products
Apo-Clindamycin · DIN 02245233 · $0.4434
Auro-Clindamycin · DIN 02436914 · $0.4434
Clindamycin · DIN 02400537 · $0.4434
Dalacin C · DIN 02182866 · not recorded
Jamp Clindamycin Capsules · DIN 02557886 · $0.4434
Jamp-Clindamycin · DIN 02483742 · $0.4434
Med-Clindamycin · DIN 02462664 · $0.4434
NRA-Clindamycin · DIN 02493756 · $0.4434
Riva-Clindamycin · DIN 02468484 · $0.4434
Teva-Clindamycin · DIN 02241710 · $0.4434
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02479931
Shortage record checked October 6, 2026
Med-Clindamycin · DIN 02462664 · 300 mg · capsule
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
1 brand, same coverage
Med-Clindamycin · DIN 02462664
Manufacturer: Generic Medical Partners Inc.; listing date 2022-04-29
Health Canada: Marketed since 2021-12-22 · brand MED-CLINDAMYCIN · ATC J01FF01 CLINDAMYCIN · form Capsule · route Oral · ingredients CLINDAMYCIN (CLINDAMYCIN HYDROCHLORIDE) 300 MG · company Generic medical partners inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordMed-Clindamycin: Formulary list price $0.44 per unit (the source does not state the unit; exact figure $0.4434). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02462664)
Source record
DIN 02462664: Med-Clindamycin
Raw flags: sec3=Y
Item: 081228088; group id 44; item number 0101; lccId None; manufacturer id GMP
Source form: Cap; strength: 300mg
Recorded listing: General benefit
Source prices (unrounded): $0.4434; ministry $0.4434
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02462664
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=95046
Interchangeable products
Apo-Clindamycin · DIN 02245233 · $0.4434
Auro-Clindamycin · DIN 02436914 · $0.4434
Clindamycin · DIN 02400537 · $0.4434
Dalacin C · DIN 02182866 · not recorded
Jamp Clindamycin Capsules · DIN 02557886 · $0.4434
Jamp-Clindamycin · DIN 02483742 · $0.4434
M-Clindamycin · DIN 02479931 · $0.4434
NRA-Clindamycin · DIN 02493756 · $0.4434
Riva-Clindamycin · DIN 02468484 · $0.4434
Teva-Clindamycin · DIN 02241710 · $0.4434
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02462664
Shortage record checked October 6, 2026
NRA-Clindamycin · DIN 02493756 · 300 mg · capsule
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
1 brand, same coverage
NRA-Clindamycin · DIN 02493756
Manufacturer: Nora Pharma; listing date 2020-10-30
Health Canada: Marketed since 2020-07-06 · brand NRA-CLINDAMYCIN · ATC J01FF01 CLINDAMYCIN · form Capsule · route Oral · ingredients CLINDAMYCIN (CLINDAMYCIN HYDROCHLORIDE) 300 MG · company Nora pharma inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordNRA-Clindamycin: Formulary list price $0.44 per unit (the source does not state the unit; exact figure $0.4434). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02493756)
Source record
DIN 02493756: NRA-Clindamycin
Raw flags: sec3=Y
Item: 081228088; group id 44; item number 0101; lccId None; manufacturer id NRA
Source form: Cap; strength: 300mg
Recorded listing: General benefit
Source prices (unrounded): $0.4434; ministry $0.4434
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02493756
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=98374
Interchangeable products
Apo-Clindamycin · DIN 02245233 · $0.4434
Auro-Clindamycin · DIN 02436914 · $0.4434
Clindamycin · DIN 02400537 · $0.4434
Dalacin C · DIN 02182866 · not recorded
Jamp Clindamycin Capsules · DIN 02557886 · $0.4434
Jamp-Clindamycin · DIN 02483742 · $0.4434
M-Clindamycin · DIN 02479931 · $0.4434
Med-Clindamycin · DIN 02462664 · $0.4434
Riva-Clindamycin · DIN 02468484 · $0.4434
Teva-Clindamycin · DIN 02241710 · $0.4434
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02493756
Shortage record checked October 6, 2026
Riva-Clindamycin · DIN 02468484 · 300 mg · capsule
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
1 brand, same coverage
Riva-Clindamycin · DIN 02468484
Manufacturer: Laboratoire Riva Inc.; listing date 2021-08-31
Health Canada: Marketed since 2017-10-13 · brand RIVA-CLINDAMYCIN · ATC J01FF01 CLINDAMYCIN · form Capsule · route Oral · ingredients CLINDAMYCIN (CLINDAMYCIN HYDROCHLORIDE) 300 MG · company Laboratoire riva inc. · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordRiva-Clindamycin: Formulary list price $0.44 per unit (the source does not state the unit; exact figure $0.4434). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02468484)
Source record
DIN 02468484: Riva-Clindamycin
Raw flags: sec3=Y
Item: 081228088; group id 44; item number 0101; lccId None; manufacturer id RIA
Source form: Cap; strength: 300mg
Recorded listing: General benefit
Source prices (unrounded): $0.4434; ministry $0.4434
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02468484
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=95691
Interchangeable products
Apo-Clindamycin · DIN 02245233 · $0.4434
Auro-Clindamycin · DIN 02436914 · $0.4434
Clindamycin · DIN 02400537 · $0.4434
Dalacin C · DIN 02182866 · not recorded
Jamp Clindamycin Capsules · DIN 02557886 · $0.4434
Jamp-Clindamycin · DIN 02483742 · $0.4434
M-Clindamycin · DIN 02479931 · $0.4434
Med-Clindamycin · DIN 02462664 · $0.4434
NRA-Clindamycin · DIN 02493756 · $0.4434
Teva-Clindamycin · DIN 02241710 · $0.4434
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02468484
Shortage record checked October 6, 2026
Teva-Clindamycin · DIN 02241710 · 300 mg · capsule
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
1 brand, same coverage
Teva-Clindamycin · DIN 02241710
Manufacturer: Teva Canada Limited; listing date 2000-11-30
Health Canada: Marketed since 2011-01-24 · brand TEVA-CLINDAMYCIN · ATC J01FF01 CLINDAMYCIN · form Capsule · route Oral · ingredients CLINDAMYCIN (CLINDAMYCIN HYDROCHLORIDE) 300 MG · company Teva canada limited · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordTeva-Clindamycin: Formulary list price $0.44 per unit (the source does not state the unit; exact figure $0.4434). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02241710)
Source record
DIN 02241710: Teva-Clindamycin
Raw flags: sec3=Y
Item: 081228088; group id 44; item number 0101; lccId None; manufacturer id TEV
Source form: Cap; strength: 300mg
Recorded listing: General benefit
Source prices (unrounded): $0.4434; ministry $0.4434
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02241710
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=65372
Interchangeable products
Apo-Clindamycin · DIN 02245233 · $0.4434
Auro-Clindamycin · DIN 02436914 · $0.4434
Clindamycin · DIN 02400537 · $0.4434
Dalacin C · DIN 02182866 · not recorded
Jamp Clindamycin Capsules · DIN 02557886 · $0.4434
Jamp-Clindamycin · DIN 02483742 · $0.4434
M-Clindamycin · DIN 02479931 · $0.4434
Med-Clindamycin · DIN 02462664 · $0.4434
NRA-Clindamycin · DIN 02493756 · $0.4434
Riva-Clindamycin · DIN 02468484 · $0.4434
Shortage status: shortage reported ended May 5, 2026 (report last updated May 5, 2026); confirm supply with the pharmacy; reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02241710
Shortage record checked October 6, 2026
Riva-Clindamycin · DIN 02468476 · 150 mg · capsule
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
1 brand, same coverage
Riva-Clindamycin · DIN 02468476
Manufacturer: Laboratoire Riva Inc.; listing date 2021-09-30
Daily cost (source): $1.7736
Health Canada: Dormant since 2025-07-22 · brand RIVA-CLINDAMYCIN · ATC J01FF01 CLINDAMYCIN · form Capsule · route Oral · ingredients CLINDAMYCIN (CLINDAMYCIN HYDROCHLORIDE) 150 MG · company Laboratoire riva inc. · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordRiva-Clindamycin: Formulary list price $0.22 per unit (the source does not state the unit; exact figure $0.2217). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02468476)
Source record
DIN 02468476: Riva-Clindamycin
Raw flags: sec3=Y
Item: 081228006; group id 44; item number 0100; lccId None; manufacturer id RIA
Source form: Cap; strength: 150mg
Recorded listing: General benefit
Source prices (unrounded): $0.2217; ministry $0.2217
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02468476
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=95690
Interchangeable products
Apo-Clindamycin · DIN 02245232 · $0.2217
Auro-Clindamycin · DIN 02436906 · $0.2217
Clindamycin · DIN 02400529 · $0.2217
Dalacin C · DIN 00030570 · not recorded
Jamp Clindamycin Capsules · DIN 02557878 · $0.2217
Jamp-Clindamycin · DIN 02483734 · $0.2217
M-Clindamycin · DIN 02479923 · $0.2217
Med-Clindamycin · DIN 02462656 · $0.2217
NRA-Clindamycin · DIN 02493748 · $0.2217
Teva-Clindamycin · DIN 02241709 · $0.2217
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02468476
Shortage record checked October 6, 2026
Health Canada lists this DIN as Dormant since July 22, 2025 — choose a marketed DIN from the same-category list.
Apo-Clindamycin · DIN 02245232 · 150 mg · capsule
General benefit; Health Canada lists this DIN as Cancelled post market since 2025-04-17 — choose a marketed DIN from the same-category list.Discontinued April 17, 2025 · checked October 5, 2026
StatusGeneral benefit; Health Canada lists this DIN as Cancelled post market since 2025-04-17 — choose a marketed DIN from the same-category list.
Write on scriptno code needed; Health Canada lists this DIN as Cancelled post market since 2025-04-17 — choose a marketed DIN from the same-category list.
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
1 brand, same coverage
Apo-Clindamycin · DIN 02245232
Manufacturer: Apotex Inc.; listing date 2002-07-29
Daily cost (source): $1.7736
Health Canada: Cancelled post market since 2025-04-17 · brand APO-CLINDAMYCIN · ATC J01FF01 CLINDAMYCIN · form Capsule · route Oral · ingredients CLINDAMYCIN (CLINDAMYCIN HYDROCHLORIDE) 150 MG · company Apotex inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordApo-Clindamycin: Formulary list price $0.22 per unit (the source does not state the unit; exact figure $0.2217). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02245232)
Source record
DIN 02245232: Apo-Clindamycin
Raw flags: sec3=Y
Item: 081228006; group id 44; item number 0100; lccId None; manufacturer id APX
Source form: Cap; strength: 150mg
Recorded listing: General benefit
Source prices (unrounded): $0.2217; ministry $0.2217
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02245232
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=69247
Interchangeable products
Auro-Clindamycin · DIN 02436906 · $0.2217
Clindamycin · DIN 02400529 · $0.2217
Dalacin C · DIN 00030570 · not recorded
Jamp Clindamycin Capsules · DIN 02557878 · $0.2217
Jamp-Clindamycin · DIN 02483734 · $0.2217
M-Clindamycin · DIN 02479923 · $0.2217
Med-Clindamycin · DIN 02462656 · $0.2217
NRA-Clindamycin · DIN 02493748 · $0.2217
Riva-Clindamycin · DIN 02468476 · $0.2217
Teva-Clindamycin · DIN 02241709 · $0.2217
Shortage status: discontinued (May 21, 2019, reported by APOTEX INC); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02245232
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since April 17, 2025 — choose a marketed DIN from the same-category list.
Apo-Clindamycin · DIN 02245233 · 300 mg · capsule
General benefit; Health Canada lists this DIN as Cancelled post market since 2025-04-17 — choose a marketed DIN from the same-category list.Discontinued April 17, 2025 · checked October 5, 2026
StatusGeneral benefit; Health Canada lists this DIN as Cancelled post market since 2025-04-17 — choose a marketed DIN from the same-category list.
Write on scriptno code needed; Health Canada lists this DIN as Cancelled post market since 2025-04-17 — choose a marketed DIN from the same-category list.
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
1 brand, same coverage
Apo-Clindamycin · DIN 02245233
Manufacturer: Apotex Inc.; listing date 2002-07-29
Health Canada: Cancelled post market since 2025-04-17 · brand APO-CLINDAMYCIN · ATC J01FF01 CLINDAMYCIN · form Capsule · route Oral · ingredients CLINDAMYCIN (CLINDAMYCIN HYDROCHLORIDE) 300 MG · company Apotex inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordApo-Clindamycin: Formulary list price $0.44 per unit (the source does not state the unit; exact figure $0.4434). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02245233)
Source record
DIN 02245233: Apo-Clindamycin
Raw flags: sec3=Y
Item: 081228088; group id 44; item number 0101; lccId None; manufacturer id APX
Source form: Cap; strength: 300mg
Recorded listing: General benefit
Source prices (unrounded): $0.4434; ministry $0.4434
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02245233
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=69248
Interchangeable products
Auro-Clindamycin · DIN 02436914 · $0.4434
Clindamycin · DIN 02400537 · $0.4434
Dalacin C · DIN 02182866 · not recorded
Jamp Clindamycin Capsules · DIN 02557886 · $0.4434
Jamp-Clindamycin · DIN 02483742 · $0.4434
M-Clindamycin · DIN 02479931 · $0.4434
Med-Clindamycin · DIN 02462664 · $0.4434
NRA-Clindamycin · DIN 02493756 · $0.4434
Riva-Clindamycin · DIN 02468484 · $0.4434
Teva-Clindamycin · DIN 02241710 · $0.4434
Shortage status: discontinued (July 12, 2019, reported by APOTEX INC); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02245233
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since April 17, 2025 — choose a marketed DIN from the same-category list.
Dalacin C · DIN 00030570 · 150 mg · capsule
Listed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2024-10-24 — choose a marketed DIN from the same-category list.Discontinued October 24, 2024 · checked October 5, 2026
StatusListed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2024-10-24 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record (an EAP request with clinical rationale is still possible); see alternatives; Health Canada lists this DIN as Cancelled post market since 2024-10-24 — choose a marketed DIN from the same-category list.
Patient paysNot paid by ODB 65 and over; see alternatives
1 brand, same coverage
Dalacin C · DIN 00030570
Manufacturer: Pfizer Canada Inc.; listing date 1996-10-01
Daily cost (source): $1.7736
Health Canada: Cancelled post market since 2024-10-24 · brand DALACIN C 150 MG · ATC J01FF01 CLINDAMYCIN · form Capsule · route Oral · ingredients CLINDAMYCIN (CLINDAMYCIN HYDROCHLORIDE) 150 MG · company Pfizer canada ulc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordDalacin C: Formulary list price None per unit (the source does not state the unit; exact figure not recorded). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00030570)
Source record
DIN 00030570: Dalacin C
Raw flags: notABenefit=Y, sec3=Y
Item: 081228006; group id 44; item number 0100; lccId None; manufacturer id PFI
Source form: Cap; strength: 150mg
Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category
Source prices (unrounded): not recorded; ministry not recorded
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00030570
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=874
Interchangeable products
Apo-Clindamycin · DIN 02245232 · $0.2217
Auro-Clindamycin · DIN 02436906 · $0.2217
Clindamycin · DIN 02400529 · $0.2217
Jamp Clindamycin Capsules · DIN 02557878 · $0.2217
Jamp-Clindamycin · DIN 02483734 · $0.2217
M-Clindamycin · DIN 02479923 · $0.2217
Med-Clindamycin · DIN 02462656 · $0.2217
NRA-Clindamycin · DIN 02493748 · $0.2217
Riva-Clindamycin · DIN 02468476 · $0.2217
Teva-Clindamycin · DIN 02241709 · $0.2217
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=00030570
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since October 24, 2024 — choose a marketed DIN from the same-category list.
Dalacin C · DIN 02182866 · 300 mg · capsule
Listed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2024-10-24 — choose a marketed DIN from the same-category list.Discontinued October 24, 2024 · checked November 16, 2026
StatusListed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2024-10-24 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record (an EAP request with clinical rationale is still possible); see alternatives; Health Canada lists this DIN as Cancelled post market since 2024-10-24 — choose a marketed DIN from the same-category list.
Patient paysNot paid by ODB 65 and over; see alternatives
1 brand, same coverage
Dalacin C · DIN 02182866
Manufacturer: Pfizer Canada Inc.; listing date 1996-12-19
Health Canada: Cancelled post market since 2024-10-24 · brand DALACIN C 300 MG · ATC J01FF01 CLINDAMYCIN · form Capsule · route Oral · ingredients CLINDAMYCIN (CLINDAMYCIN HYDROCHLORIDE) 300 MG · company Pfizer canada ulc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordDalacin C: Formulary list price None per unit (the source does not state the unit; exact figure not recorded). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02182866)
Source record
DIN 02182866: Dalacin C
Raw flags: notABenefit=Y, sec3=Y
Item: 081228088; group id 44; item number 0101; lccId None; manufacturer id PFI
Source form: Cap; strength: 300mg
Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category
Source prices (unrounded): not recorded; ministry not recorded
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02182866
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=19455
Interchangeable products
Apo-Clindamycin · DIN 02245233 · $0.4434
Auro-Clindamycin · DIN 02436914 · $0.4434
Clindamycin · DIN 02400537 · $0.4434
Jamp Clindamycin Capsules · DIN 02557886 · $0.4434
Jamp-Clindamycin · DIN 02483742 · $0.4434
M-Clindamycin · DIN 02479931 · $0.4434
Med-Clindamycin · DIN 02462664 · $0.4434
NRA-Clindamycin · DIN 02493756 · $0.4434
Riva-Clindamycin · DIN 02468484 · $0.4434
Teva-Clindamycin · DIN 02241710 · $0.4434
Shortage status: discontinued (October 29, 2024, reported by PFIZER CANADA ULC); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02182866
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since October 24, 2024 — choose a marketed DIN from the same-category list.
Other drugs in the same formulary classes and how they are covered
Other drugs in the same formulary class (08:12:28 Other Antibiotics) and how they are covered
Matched class: 08:12:28 Other Antibiotics
Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment.
Public program routes: ODB 65 and over
Covered without a code on the Ontario formulary: CEFIXIME
Some products covered without a code (check the product listing): CEFADROXIL, CEFPROZIL, CEFTRIAXONE DISODIUM, CEFUROXIME AXETIL, CEPHALEXIN MONOHYDRATE, TOBRAMYCIN, TOBRAMYCIN SULFATE
08:12:28 Other Antibiotics
· 4 products · Listed, not a benefit (1), General benefit (3) · strengths: 500mg · Cap
· 4 products · General benefit · strengths: 20mg/mL, 400mg · Oral Susp, Tab
· 17 products · General benefit (11), Listed, not a benefit (6) · strengths: 125mg/5mL, 250mg/5mL, 250mg, 500mg · Oral Susp-100mL Pk, Oral Susp-75mL Pk, Tab
· 16 products · Listed, not a benefit (3), General benefit (9), General benefit; DIN status E (meaning unconfirmed); confirm discontinuation/availability with Health Canada (1), Off-Formulary Interchangeable, not an ODB benefit (3) · strengths: 0.25g/Vial, 1g/Vial, 2g/Vial, 10g/Vial · Inj Pd-Vial Pk
· 9 products · General benefit (7), Listed, not a benefit (2) · strengths: 125mg/5mL, 250mg, 500mg · Susp, Tab
· 29 products · Listed, not a benefit (6), General benefit (23) · strengths: 250mg, 500mg, 25mg/mL, 50mg/mL · Cap, Pd for Oral Susp, Tab
· 3 products ·
Limited Use, codes 472 (1), General benefit (2) · strengths: 28mg, 300mg/5mL · Inh Pd-Cap, Inh Sol-5mL Pk
· 4 products · Listed, not a benefit (1), General benefit (3) · strengths: 80mg/2mL · Inj Sol-2mL Pk
· 1 products ·
Limited Use, codes 677 · strengths: 500mg/Vial · Pd for Sol (Preservative-Free)
· 1 products ·
Limited Use, codes 475 · strengths: 550mg · Tab
· 4 products ·
Limited Use, codes 557, 558, 559, 560 (2), Off-Formulary Interchangeable, not an ODB benefit (2) · strengths: 125mg, 250mg · Cap
· 15 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 500mg/Vial, 1g/Vial, 10g/Vial · Inj Pd-Vial Pk, Inj Pd-Vial Pk (Preservative-Free)
Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=2026-09-22; class 08:12:28
and 2 more
Full class listing
Related classes: 08:12:04 Antifungals, 08:12:07 Carbapenems, 08:12:12 Erythromycins, 08:12:16 Penicillins, 08:12:24 Tetracyclines, 08:14:08 Azoles
Other drugs in the same formulary class (84:04:04 Antibiotics) and how they are covered
Matched class: 84:04:04 Antibiotics
Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment.
Public program routes: ODB 65 and over
Covered without a code on the Ontario formulary: FUSIDIC ACID, MUPIROCIN CALCIUM, SODIUM FUSIDATE
Some products covered without a code (check the product listing): MUPIROCIN
84:04:04 Antibiotics
· 2 products · General benefit · strengths: 2% · Cr
· 2 products · Listed, not a benefit (1), General benefit (1) · strengths: 2% · Oint
· 1 products · General benefit · strengths: 2% w/w · Cr
· 2 products · General benefit · strengths: 2% · Oint
Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=2026-09-22; class 84:04:04
Full class listing
Related classes: 84:04:08 Fungicides, 84:04:12 Parasiticides, 84:04:16 Other Anti-Infectives
Same formulary class, not same indication: class membership alone does not establish equivalent uses.
Other drugs whose Health Canada label lists a similar indication: acne, bone and joint infections, gynecological infections, intra-abdominal infections, septicemia, skin and skin structure infections
From Health Canada product monographs; label wording only, not a treatment recommendation.
Matching is lexical and uses one held product label per generic; formulations and qualifying criteria may differ.
No displayed matched alternative is a general benefit.
CEFOXITIN SODIUM · Off-Formulary Interchangeable, not an ODB benefit
1 - Intra-abdominal infections such as peritonitis and intra-abdominal abscess
PM: https://pdf.hres.ca/dpd_pm/00073366.PDF; date November 16, 2023; DIN 02128187; fetched 2026-09-10
Product monograph
2 - Gynecological infections such as endometritis and pelvic cellulitis
PM: https://pdf.hres.ca/dpd_pm/00073366.PDF; date November 16, 2023; DIN 02128187; fetched 2026-09-10
Product monograph
3 - Septicemia
PM: https://pdf.hres.ca/dpd_pm/00073366.PDF; date November 16, 2023; DIN 02128187; fetched 2026-09-10
Product monograph
6 - Bone and joint infections caused by Staphylococcus aureus
PM: https://pdf.hres.ca/dpd_pm/00073366.PDF; date November 16, 2023; DIN 02128187; fetched 2026-09-10
Product monograph
CEFTRIAXONE DISODIUM · Listed, not a benefit (3), General benefit (9), General benefit; DIN status E (meaning unconfirmed); confirm discontinuation/availability with Health Canada (1), Off-Formulary Interchangeable, not an ODB benefit (3)
• Skin and Skin Structure Infections caused by K. pneumoniae and species, P. mirabilis, Staph. aureus,
Staph. epidermidis and Streptococcus species (excluding enterococci).
PM: https://pdf.hres.ca/dpd_pm/00071552.PDF; date MAY 15, 2023; DIN 02289695; fetched 2026-09-10
Product monograph
• Bone and Joint Infections caused by Staph. aureus, Strep. pneumoniae and Streptococcus species
(excluding enterococci).
PM: https://pdf.hres.ca/dpd_pm/00071552.PDF; date MAY 15, 2023; DIN 02289695; fetched 2026-09-10
Product monograph
• Intra-Abdominal Infections caused by E.coli and K. pneumoniae.
PM: https://pdf.hres.ca/dpd_pm/00071552.PDF; date MAY 15, 2023; DIN 02289695; fetched 2026-09-10
Product monograph
CEFADROXIL · Listed, not a benefit (1), General benefit (3)
• Skin and skin structure infections caused by Staphylococcus aureus and/or Group A ß–
hemolytic streptococci.
PM: https://pdf.hres.ca/dpd_pm/00056563.PDF; date May 20, 2020; DIN 02235134; fetched 2026-09-10
Product monograph
TAZAROTENE · Limited Use, codes 636
1 INDICATIONS
ARAZLO™ (tazarotene lotion), is indicated for:
• For the topical treatment of acne vulgaris in patients 10 years of age and older.
1.1 Pediatrics
Pediatrics (≥ 10 years of age)
The safety and efficacy of ARAZLO in pediatric patients (10 years of age and older) has been
established.
PM: https://pdf.hres.ca/dpd_pm/00082613.PDF; date NOV 28, 2025; DIN 02517868; fetched 2026-09-10
Product monograph
Coverage source: ON formulary extract 2026-09-22
Availability
Taro-Clindamycin · DIN 02266938
Shortage status: discontinued (2026-05-19, reported by TARO PHARMACEUTICALS INC); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02266938
Check this DIN againDalacin T 1% · DIN 00582301
Shortage status: active shortage (reported 2018-01-26, last updated 2019-03-11) — report may be stale, confirm; reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=00582301
Check this DIN againJamp-Clindamycin · DIN 02483734
Shortage status: active shortage (reported 2026-09-15, estimated to end 2026-10-22, last updated 2026-09-23); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02483734
Check this DIN againTeva-Clindamycin · DIN 02241709
Shortage status: active shortage (reported 2025-10-08, last updated 2025-10-10); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02241709
Check this DIN againJamp-Clindamycin · DIN 02483742
Shortage status: active shortage (reported 2026-09-15, estimated to end 2026-10-22, last updated 2026-09-23); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02483742
Check this DIN againTeva-Clindamycin · DIN 02241710
Shortage status: shortage reported ended 2026-05-05 (report last updated 2026-05-05); confirm supply with the pharmacy; reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02241710
Check this DIN againApo-Clindamycin · DIN 02245232
Shortage status: discontinued (2019-05-21, reported by APOTEX INC); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02245232
Check this DIN againApo-Clindamycin · DIN 02245233
Shortage status: discontinued (2019-07-12, reported by APOTEX INC); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02245233
Check this DIN againDalacin C · DIN 02182866
Shortage status: discontinued (2024-10-29, reported by PFIZER CANADA ULC); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02182866
Check this DIN again